These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 6632196

  • 1. [Treatment of relapsing acute leukemia].
    Yamada K, Kato Y.
    Gan No Rinsho; 1983 Aug; 29(10):1092-5. PubMed ID: 6632196
    [Abstract] [Full Text] [Related]

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 3. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S, Paydas S, Disel U, Sahin B.
    Am J Ther; 2006 May; 13(5):389-93. PubMed ID: 16988532
    [Abstract] [Full Text] [Related]

  • 4. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
    Peterson BA, Bloomfield CD, Theologides A, Kennedy BJ.
    Cancer Treat Rep; 1981 May; 65 Suppl 4():29-33. PubMed ID: 6955011
    [Abstract] [Full Text] [Related]

  • 5. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia.
    Bloomfield CD, Shuma C, Regal L, Philip PP, Hossfeld DK, Hagemeijer AM, Garson OM, Peterson BA, Sakurai M, Alimena G, Berger R, Rowley JD, Ruutu T, Mitelman F, Dewald GW, Swansbury J.
    Cancer; 1997 Dec 01; 80(11 Suppl):2191-8. PubMed ID: 9395033
    [Abstract] [Full Text] [Related]

  • 6. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
    Reman O, Pigneux A, Huguet F, Vey N, Delannoy A, Fegueux N, de Botton S, Stamatoullas A, Tournilhac O, Buzyn A, Charrin C, Boucheix C, Gabert J, Lhéritier V, Vernant JP, Fière D, Dombret H, Thomas X, GET-LALA group.
    Leuk Res; 2008 Nov 01; 32(11):1741-50. PubMed ID: 18508120
    [Abstract] [Full Text] [Related]

  • 7. A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia.
    Bassan R, Lerede T, Buelli M, Borleri G, Bellavita P, Rambaldi A, Barbui T.
    Haematologica; 1998 May 01; 83(5):422-7. PubMed ID: 9658726
    [Abstract] [Full Text] [Related]

  • 8. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
    Singhal S, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Mehta J.
    Bone Marrow Transplant; 1996 Apr 01; 17(4):637-41. PubMed ID: 8722368
    [Abstract] [Full Text] [Related]

  • 9. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
    Mehta J, Powles R, Singhal S, Horton C, Tait D, Treleaven J.
    Bone Marrow Transplant; 1996 Jul 01; 18(1):119-23. PubMed ID: 8832004
    [Abstract] [Full Text] [Related]

  • 10. [A clinical study of sixteen polycythemia vera cases--acute myeloblastic leukemia in patients with polycythemia vera].
    Takeyama H, Shimokawa T, Yamada H, Watanabe E.
    Gan To Kagaku Ryoho; 1994 Dec 01; 21(16):2833-7. PubMed ID: 7993124
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
    Brice P, Bouabdallah R, Moreau P, Divine M, André M, Aoudjane M, Fleury J, Anglaret B, Baruchel A, Sensebe L, Colombat P.
    Bone Marrow Transplant; 1997 Jul 01; 20(1):21-6. PubMed ID: 9232251
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Response-oriented salvage chemotherapy with mitoxantrone, etoposide and enocitabine for previously treated acute myeloid leukemia. Tohoku Leukemia Study Group].
    Chubachi A, Kuriya S, Narigasawa Y, Meguro K, Endo K, Takami H, Sato S, Sasaki H, Shiga T, Maruyama Y.
    Gan To Kagaku Ryoho; 1995 Dec 01; 22(14):2101-6. PubMed ID: 8607622
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia.
    Mollee P, Gupta V, Song K, Reddy V, Califaretti N, Tsang R, Crump M, Keating A.
    Bone Marrow Transplant; 2004 Jun 01; 33(12):1201-8. PubMed ID: 15094745
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.